Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and icatibant

n-methyl-3,4-methylenedioxyamphetamine has been researched along with icatibant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Del Baño, F; Escalante, FA; Supervía, A1
Del Baño, F; Escolano, F; Supervía, A1

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and icatibant

ArticleYear
MDMA-induced angioedema treated with icatibant.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:10

    Topics: Adult; Angioedema; Bradykinin; Bradykinin B2 Receptor Antagonists; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Treatment Outcome

2015
Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate.
    Medicina clinica, 2021, 01-22, Volume: 156, Issue:2

    Topics: Angioedema; Angioedemas, Hereditary; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Humans; N-Methyl-3,4-methylenedioxyamphetamine

2021